From March 22 to 24, 2025, the 22nd China International Exhibition on Clinical Laboratory Medicine and Transfusion Medicine (CACLP 2025) grandly commenced at the Hangzhou International Expo Center. As a premier global event in the field of in vitro diagnostics (IVD), CACLP brings together top-tier enterprises, cutting-edge technologies, and industry experts to explore the latest trends in the IVD sector. Hangzhou Singclean Medical showcased a series of groundbreaking products. Among them, the Quickclean HIV1/2 Urine Antibody Test Kit became the center of attention, drawing significant industry interest.
Revolutionizing HIV Testing: Ushering in the Era of Non-Invasive Self-Testing
Singclean Medical's newly launched Quickclean HIV Urine Antibody Test Kit surpasses traditional testing methods with its three core advantages-high accuracy, high convenience, and high privacy-filling a critical technological gap in the global HIV self-testing field.
Data shows that compared to serum testing, the urine test kit achieves a 98.8% positive agreement rate and a 100% negative agreement rate, with an overall self-test accuracy reaching an impressive 99.9%, demonstrating reliability comparable to professional laboratory testing. The kit features an innovative non-invasive urine sampling method, eliminating the pain and invasiveness of traditional blood tests, making it particularly suitable for high-risk individuals who require enhanced privacy protection.
What's more, Quickclean HIV Urine Antibody Test Kit is user-friendly, providing results in just 15-20 minutes. Its waste disposal is non-biohazardous and can be treated as regular household waste, significantly lowering the barriers to testing and reducing public health management costs. Experts at the event praised this breakthrough, noting that it not only empowers individuals with an early detection and intervention solution for home-based HIV self-testing but also enables healthcare institutions to conduct low-cost, high-efficiency HIV screening, injecting new momentum into the global fight against AIDS.
Showcasing a Comprehensive IVD Portfolio: Full-Spectrum Industry Presence
Beyond the HIV test kit, Singclean Medical presented an extensive portfolio covering eight major product categories within the IVD sector. These include:
Women's health and fertility testing (HCG, LH, BV, etc.)
Infectious disease detection (COVID-19, monkeypox, dengue fever, etc.)
Drug abuse screening
Cardiovascular, inflammation, and tumor marker diagnostics
This comprehensive product line spans the full cycle of disease prevention, diagnosis, and health management.
HIV1/2 Urine Antibody Test Kit
(This product is not available on the market in China)
Over the past 23 years, Singclean Medical has remained at the forefront of medical technology innovation. Initially specializing in hyaluronic acid technology, the company has expanded into a diversified industrial ecosystem that integrates diagnostic reagents, medical aesthetics products, and CDMO services. Currently, Singclean Medical is actively developing recombinant collagen and regenerative materials within the medical aesthetics sector, with over ten upcoming products in the pipeline. Through global supply chain integration, the company is also committed to providing technological transformation and product commercialization support for international clients.
Rooted in Hangzhou, Serving the World: The Innovation DNA of Singclean Medical
"From diagnostics to treatment, from medical care to health management, Singclean Medical is dedicated to driving industry progress through technological innovation," stated a company representative. As a high-tech enterprise nurtured in Hangzhou, Singclean Medical leverages the biopharmaceutical industry cluster and continues to strengthen its R&D efforts!
Looking ahead, Singclean Medical is accelerating its global expansion strategy, committed to delivering more precise and accessible medical solutions while fulfilling its mission: "Bringing a healthier future to users worldwide."
Singclean Medical's presence at CACLP 2025 not only underscores its strong expertise in the IVD sector but also reflects China's shift from an industry follower to a global leader in medical innovation. As demand for precision medicine and home-based diagnostics continues to surge, Singclean Medical's pioneering efforts are set to unlock new possibilities for global public health initiatives.